Pharmaceuticals Stocks
173 只股票追踪中 在 Pharmaceuticals
| 股票代码 | 公司 | 市值 | P/E | 信号 |
|---|---|---|---|---|
| AARD | Aardvark Therapeutics, Inc. - Common Stock | $95.1M | — | — |
| ACB | Aurora Cannabis Inc. - Common Shares | $327.2M | — | — |
| ACRS | Aclaris Therapeutics, Inc. - Common Stock | $692.0M | — | — |
| ADIL | Adial Pharmaceuticals, Inc - Common Stock | $2.1M | — | — |
| ADXN | Addex Therapeutics Ltd - American Depositary Shares | $8.1M | — | — |
| AKAN | Akanda Corp. - Common Shares | $333K | — | — |
| ALMS | Alumis Inc. - Common Stock | $2.9B | — | — |
| AMLX | Amylyx Pharmaceuticals, Inc. - Common Stock | $1.8B | — | — |
| AMPH | Amphastar Pharmaceuticals, Inc. - Common Stock | $808.9M | 8.2 | 1 |
| AMRX | Amneal Pharmaceuticals, Inc. - Class A Common Stock | $4.0B | 671.4 | — |
| ANIP | ANI Pharmaceuticals, Inc. - Common Stock | $1.9B | 24.3 | — |
| ANRO | Alto Neuroscience, Inc. Common Stock | $832.5M | — | — |
| ANTX | AN2 Therapeutics, Inc. - Common Stock | $169.9M | — | — |
| AQST | Aquestive Therapeutics, Inc. - Common Stock | $510.2M | — | — |
| ARTL | Artelo Biosciences, Inc. - Common Stock | $2.5M | — | — |
| ARVN | Arvinas, Inc. - Common Stock | $761.7M | — | — |
| ASBP | Aspire Biopharma Holdings, Inc. - Common Stock | $18.3M | — | — |
| ASRT | Assertio Holdings, Inc. - Common Stock | $145.0M | — | — |
| ATAI | AtaiBeckley Inc. - Common Stock | $1.5B | — | — |
| AVIR | Atea Pharmaceuticals, Inc. - common stock | $431.0M | — | — |
| AXSM | Axsome Therapeutics, Inc. - Common Stock | $9.2B | — | — |
| AYTU | Aytu BioPharma, Inc. - Common Stock | $24.1M | — | — |
| AZN | AstraZeneca PLC - American Depositary Shares | $213.8B | 30.6 | 3 |
| BFRI | Biofrontera Inc. - Common Stock | $11.2M | — | — |
| BGM | BGM Group Ltd. - Class A Ordinary Shares | $678.8M | — | — |
| BHC | Bausch Health Companies Inc. Common Stock | $2.9B | 13.6 | — |
| BIOA | BioAge Labs, Inc. - Common Stock | $798.7M | — | — |
| BLTE | Belite Bio, Inc - American Depositary Shares | $5.6B | — | — |
| BMY | Bristol-Myers Squibb Company Common Stock | $119.0B | 16.9 | — |
| BTMD | Biote Corp. - Class A common stock | $85.7M | 3.2 | — |
| CALC | CalciMedica, Inc. - Common Stock | $10.4M | — | — |
| CGC | Canopy Growth Corporation - Common Shares | $574.8M | — | — |
| CGTX | Cognition Therapeutics, Inc. - Common Stock | $102.0M | — | — |
| CING | Cingulate Inc. - Common Stock | $56.0M | — | — |
| CMND | Clearmind Medicine Inc. - Common Shares | $2.7M | — | — |
| CNSP | CNS Pharmaceuticals, Inc. - Common Stock | $4.0M | — | — |
| CNTX | Context Therapeutics Inc. - Common Stock | $219.6M | — | — |
| COCP | Cocrystal Pharma, Inc. - Common Stock | $16.5M | — | — |
| COLL | Collegium Pharmaceutical, Inc. - Common Stock | $1.2B | 18.8 | 1 |
| CORT | Corcept Therapeutics Incorporated - Common Stock | $3.7B | 34.5 | — |
| CPIX | Cumberland Pharmaceuticals Inc. - Common Stock | $68.2M | — | — |
| CRDL | Cardiol Therapeutics Inc. - Class A Common Shares | $131.0M | — | — |
| CRMD | CorMedix Inc. - Common Stock | $588.2M | 3.6 | — |
| CRNX | Crinetics Pharmaceuticals, Inc. - Common Stock | $4.6B | — | — |
| CRON | Cronos Group Inc. - Common Share | $1.4B | 27.8 | — |
| CTNM | Contineum Therapeutics, Inc. - Common stock | $510.7M | — | — |
| CTXR | Citius Pharmaceuticals, Inc. - Common Stock | $16.1M | — | — |
| CURX | Curanex Pharmaceuticals Inc - Common Stock | $9.4M | — | — |
| CVKD | Cadrenal Therapeutics, Inc. - Common Stock | $18.7M | — | — |
| DARE | Dare Bioscience, Inc. - Common Stock | $41.6M | — | — |
| DERM | Journey Medical Corporation - Common Stock | $141.8M | — | — |
| ELAN | Elanco Animal Health Incorporated Common Stock | $10.7B | — | — |
| ELVN | Enliven Therapeutics, Inc. - Common Stock | $2.4B | — | — |
| ENVB | Enveric Biosciences, Inc. - Common Stock | $2.2M | — | — |
| EOLS | Evolus, Inc. - Common Stock | $419.5M | — | — |
| ESPR | Esperion Therapeutics, Inc. - Common Stock | $805.7M | — | — |
| ETON | Eton Pharmaceuticals, Inc. - Common Stock | $819.7M | — | — |
| EWTX | Edgewise Therapeutics, Inc. - Common Stock | $4.1B | — | — |
| EYPT | EyePoint, Inc. - Common Stock | $1.5B | — | — |
| FULC | Fulcrum Therapeutics, Inc. - Common Stock | $746.1M | — | — |
| GELS | Gelteq Limited - Ordinary Shares | $8.6M | — | — |
| GHRS | GH Research PLC - Ordinary Shares | $1.5B | — | — |
| GPCR | Structure Therapeutics Inc. - American Depositary Shares | $2.8B | — | — |
| GRCE | Grace Therapeutics, Inc. - Common Stock | $53.5M | — | — |
| GSK | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | $85.1B | 14.9 | — |
| HCM | HUTCHMED (China) Limited - American Depositary Shares | $18.0B | 5.0 | — |
| HIND | Vyome Holdings, Inc. - Common Stock | $19.4M | — | — |
| HITI | High Tide Inc. - Common Shares | $319.7M | — | — |
| HLN | Haleon plc American Depositary Shares (Each representing two Ordinary Shares) | $31.4B | 18.9 | — |
| HOTH | Hoth Therapeutics, Inc. - Common Stock | $15.4M | — | — |
| HRMY | Harmony Biosciences Holdings, Inc. - Common Stock | $2.2B | 11.6 | — |
| HROW | Harrow, Inc. - Common Stock | $1.4B | — | — |
| HYPD | Hyperion DeFi, Inc. - Common Stock | $40.4M | — | — |
| IMA | ImageneBio, Inc. - Common Stock | $59.2M | — | — |
| IMCC | IM Cannabis Corp. - Common Shares | $10.6M | — | — |
| INCR | Intercure Ltd. - ordinary shares | $176.9M | — | — |
| INDV | Indivior Pharmaceuticals, Inc. - Common Stock | $4.5B | 35.8 | 1 |
| INM | InMed Pharmaceuticals Inc. - Common Shares | $3.0M | — | — |
| INVA | Innoviva, Inc. - Common Stock | $1.7B | 3.3 | — |
| IXHL | Incannex Healthcare Inc. - Common Stock | $55.3M | — | — |
| JAGX | Jaguar Health, Inc. - Common Stock | $1.5M | — | — |
| JAZZ | Jazz Pharmaceuticals plc - Ordinary Shares | $10.3B | — | — |
| JNJ | Johnson & Johnson Common Stock | $562.3B | 26.7 | — |
| JUNS | Jupiter Neurosciences, Inc. - Common Stock | $35.1M | — | — |
| KPRX | Kiora Pharmaceuticals, Inc. - Common Stock | $9.7M | — | — |
| LBRX | LB Pharmaceuticals Inc - Common Stock | $563.2M | — | — |
| LENZ | LENZ Therapeutics, Inc. - Common Stock | $313.2M | — | — |
| LEXX | Lexaria Bioscience Corp. - Common Stock | $15.4M | — | — |
| LGND | Ligand Pharmaceuticals Incorporated - Common Stock | $4.2B | 33.8 | — |
| LLY | Eli Lilly and Company Common Stock | $869.2B | 42.1 | — |
| LPCN | Lipocine Inc. - Common Stock | $19.0M | — | — |
| LQDA | Liquidia Corporation - Common Stock | $3.7B | — | — |
| LXRX | Lexicon Pharmaceuticals, Inc. - Common Stock | $847.4M | — | — |
| MANE | Veradermics, Incorporated Common Stock | $2.6B | — | — |
| MAZE | Maze Therapeutics, Inc. - Common Stock | $1.4B | — | — |
| MBX | MBX Biosciences, Inc. - Common Stock | $1.5B | — | — |
| MDWD | MediWound Ltd. - Ordinary Shares | $236.7M | — | — |
| MIRA | MIRA Pharmaceuticals, Inc. - Common Stock | $63.2M | — | — |
| MIST | Milestone Pharmaceuticals Inc. - Common Shares | $223.6M | — | — |
| MRK | Merck & Company, Inc. Common Stock (new) | $291.9B | 16.0 | — |
| NKTR | Nektar Therapeutics - Common Stock | $2.7B | — | — |
| NMRA | Neumora Therapeutics, Inc. - Common Stock | $340.9M | — | — |
| NRXP | NRX Pharmaceuticals, Inc. - Common Stock | $108.5M | — | — |
| NTHI | NeOnc Technologies Holdings, Inc. - Common Stock | $139.1M | — | — |
| NTRB | Nutriband Inc. - Common Stock | $55.3M | — | — |
| NUVB | Nuvation Bio Inc. Class A Common Stock | $1.5B | — | — |
| NVO | Novo Nordisk A/S Common Stock | $1.1T | 10.9 | — |
| NVS | Novartis AG Common Stock | $216.0B | 19.7 | — |
| OCS | Oculis Holding AG - Ordinary shares | $1.9B | — | — |
| OCUL | Ocular Therapeutix, Inc. - Common Stock | $2.1B | — | — |
| OGI | Organigram Global Inc. - Common Shares | $311.9M | — | — |
| OGN | Organon & Co. Common Stock | $2.4B | 13.0 | — |
| OMER | Omeros Corporation - Common Stock | $1.0B | — | — |
| ORMP | Oramed Pharmaceuticals Inc. - Common Stock | $113.4M | 2.6 | — |
| PAHC | Phibro Animal Health Corporation - Class A Common Stock | $1.5B | 22.4 | — |
| PBH | Prestige Consumer Healthcare Inc. Common Stock | $2.7B | 14.5 | — |
| PCRX | Pacira BioSciences, Inc. - Common Stock | $975.1M | 189.8 | — |
| PCSA | Processa Pharmaceuticals, Inc. - Common Stock | $6.5M | — | — |
| PFE | Pfizer, Inc. Common Stock | $154.8B | 19.9 | — |
| PHAT | Phathom Pharmaceuticals, Inc. - Common Stock | $969.8M | — | — |
| PHVS | Pharvaris N.V. - Ordinary Shares | $2.0B | — | — |
| PLRX | Pliant Therapeutics, Inc. - Common Stock | $71.2M | — | — |
| PPBT | Purple Biotech Ltd. - American Depositary Shares | $22.3M | — | — |
| PRFX | PRF Technologies Ltd. - Ordinary Shares | $2.5M | — | — |
| PRGO | Perrigo Company plc Ordinary Shares | $1.6B | — | — |
| PULM | Pulmatrix, Inc. - Common Stock | $8.1M | — | — |
| PYPD | PolyPid Ltd. - Ordinary Shares | $87.0M | — | — |
| QCLS | Q/C Technologies, Inc. - Common Stock | $16.6M | — | — |
| QNTM | Quantum Biopharma Ltd. - Class B Subordinate Voting Shares | $40.4M | — | — |
| RANI | Rani Therapeutics Holdings, Inc. - Class A Common Stock | $133.7M | — | — |
| RAPP | Rapport Therapeutics, Inc. - Common Stock | $1.7B | — | — |
| RDHL | Redhill Biopharma Ltd. - American Depositary Shares | $4.7M | — | — |
| RDY | Dr. Reddy's Laboratories Ltd Common Stock | $1.0T | 18.3 | — |
| RFL | Rafael Holdings, Inc. Class B Common Stock | $63.5M | — | — |
| RGC | Regencell Bioscience Holdings Limited - Ordinary Shares | $10.4B | — | — |
| RLMD | Relmada Therapeutics, Inc. - Common Stock | $781.4M | — | — |
| RPRX | Royalty Pharma plc - Class A Ordinary Shares | $22.3B | 29.2 | — |
| SCLX | Scilex Holding Company - Common Stock | $51.0M | — | — |
| SCYX | SCYNEXIS, Inc. - Common Stock | $58.8M | — | — |
| SEPN | Septerna, Inc. - Common Stock | $1.2B | — | — |
| SIGA | SIGA Technologies Inc. - Common Stock | $437.5M | 5.9 | — |
| SLGL | Sol-Gel Technologies Ltd. - Ordinary Shares | $117.4M | — | — |
| SNDL | SNDL Inc. - Common Shares | $370.7M | — | — |
| SNES | SenesTech, Inc. - Common Stock | $8.8M | — | — |
| SNOA | Sonoma Pharmaceuticals, Inc. - Common Stock | $6.2M | — | — |
| SNY | Sanofi - American Depositary Shares | $100.2B | 7.2 | 2 |
| SPRC | SciSparc Ltd. - Ordinary Shares | $4.5M | — | — |
| SUPN | Supernus Pharmaceuticals, Inc. - Common Stock | $3.0B | — | — |
| SXTC | China SXT Pharmaceuticals, Inc. - Common Stock | $185.6M | — | — |
| SXTP | 60 Degrees Pharmaceuticals, Inc. - Common Stock | $3.7M | — | — |
| TAK | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | $9.0T | 79.4 | — |
| TARS | Tarsus Pharmaceuticals, Inc. - Common Stock | $2.6B | — | — |
| TBPH | Theravance Biopharma, Inc. - Ordinary Shares | $867.1M | 7.6 | — |
| TELO | Telomir Pharmaceuticals, Inc. - Common Stock | $45.7M | — | — |
| TEVA | Teva Pharmaceutical Industries Limited American Depositary Shares | $108.9B | 25.4 | — |
| TLPH | Talphera, Inc. - Common Stock | $42.9M | — | — |
| TLRY | Tilray Brands, Inc. - Common Stock | $1.0B | — | — |
| TRAW | Traws Pharma, Inc. - Common Stock | $24.2M | 2.6 | — |
| TRVI | Trevi Therapeutics, Inc. - Common Stock | $1.6B | — | — |
| TTRX | Turn Therapeutics Inc. - Common Stock | — | — | — |
| TVRD | Tvardi Therapeutics, Inc. - Common Stock | $37.5M | — | — |
| TXMD | TherapeuticsMD, Inc. - Common Stock | $18.9M | 62.5 | — |
| UPC | Universe Pharmaceuticals Inc - Class A Ordinary Shares | $2.1M | 2.0 | — |
| VERU | Veru Inc. - Common Stock | $34.3M | — | — |
| VRCA | Verrica Pharmaceuticals Inc. - Common Stock | $125.7M | — | — |
| VTRS | Viatris Inc. - Common Stock | $18.1B | — | — |
| VYNE | VYNE Therapeutics Inc. - Common Stock | $22.3M | — | — |
| WVE | Wave Life Sciences Ltd. - Ordinary Shares | $1.4B | — | — |
| XERS | Xeris Biopharma Holdings, Inc. - Common Stock | $1.3B | — | — |
| XRTX | XORTX Therapeutics Inc. - Common Stock | $5.5M | — | — |
| ZTS | Zoetis Inc. Class A Common Stock | $50.3B | 18.8 | — |
| ZVRA | Zevra Therapeutics, Inc. - Common Stock | $676.1M | 8.1 | — |
| ZYBT | Zhengye Biotechnology Holding Limited - Ordinary Shares | $79.6M | 14.2 | — |
没有股票匹配您的筛选条件
请尝试调整搜索条件
加载更多股票...